|
|
Volumn 64, Issue 2, 2000, Pages 189-191
|
|
Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: A 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
a
|
|
Author keywords
Adjuvant treatment; Breast cancer; Chemotherapy; Immunotherapy; Radiotherapy; Randomized trial
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
METHOTREXATE;
POLYADENYLIC POLYURIDYLIC ACID;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
METASTASIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM METASTASIS;
POLY A-U;
RADIOTHERAPY, ADJUVANT;
|
|
EID: 0034541497
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006498121628 Document Type: Article |
|
Times cited : (36)
|
|
References (4)
|
